Bio-Techne's Upcoming Presentation
Bio-Techne Corporation (NASDAQ: TECH) is poised to make a significant appearance at the upcoming J.P. Morgan Healthcare Conference. Kim Kelderman, the President and CEO of the company, will take center stage at this prestigious event, scheduled for Tuesday, during the morning session. This conference serves as a key platform for investors and analysts to gain insights into the latest trends in healthcare innovation.
Key Details of the Conference
The presentation will occur on January 13, 2026, at 9:00 a.m. PST. Those interested in following the presentation can tune in to the live webcast via Bio-Techne's Investor Relations page. This opportunity provides an exciting way for stakeholders to engage with the company’s vision and future strategies in the evolving life sciences sector.
About Bio-Techne Corporation
Bio-Techne Corporation (NASDAQ: TECH) has established itself as a prominent player in the global life sciences arena, renowned for providing innovative tools and bioactive reagents essential for research and clinical diagnostics. The company’s extensive portfolio assists researchers and diagnosticians in the understanding of biological processes, the identification of diseases, and the drug discovery methods that lead to better health outcomes.
An Unmatched Product Offering
With a staggering array of products—over thousands in total—Bio-Techne's offerings are indispensable to the scientific community. In the last fiscal year, the company reported net sales exceeding $1.2 billion, demonstrating their robust growth and application in various research fields. Their core mission focuses on empowering the scientific community to achieve breakthroughs that enhance healthcare globally.
Employee Commitment and Engagement
Bio-Techne prides itself on its workforce of approximately 3,100 employees across the globe. The company fosters a culture of innovation and collaboration, ensuring that their teams are well-equipped to provide cutting-edge solutions that cater to the diverse needs of their customers. By investing in its people, Bio-Techne continues to drive progress in life sciences.
Following Bio-Techne's Journey
For anyone seeking more information about Bio-Techne and its various brands, the company offers a wealth of resources available on its website. Additionally, they maintain active channels on social media platforms, making it easy for interested individuals to stay connected and informed about ongoing developments and announcements.
Frequently Asked Questions
What is the purpose of the J.P. Morgan Healthcare Conference?
The J.P. Morgan Healthcare Conference brings together industry leaders to discuss healthcare innovation, trends, and investment opportunities.
Who will represent Bio-Techne at the conference?
Kim Kelderman, President and CEO, will represent Bio-Techne Corporation at the conference.
When will the presentation take place?
The presentation is scheduled for January 13, 2026, at 9:00 a.m. PST.
How can I access the presentation?
Interested individuals can watch the live webcast via the Investor Relations page of Bio-Techne's website.
What does Bio-Techne specialize in?
Bio-Techne specializes in providing innovative tools and reagents for research and clinical diagnostics across various biological studies.